Glycemic Response to Two Doses of Low Sugar Apple Juice

Last updated: August 3, 2021
Sponsor: Clinical Research Center Kiel GmbH
Overall Status: Completed

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT04747639
HB-RCT2-2015
  • Ages > 18
  • Male

Study Summary

Single center, double-blind, randomized controlled cross-over trial with four treatments and four time points.

The study has three primary objectives. The first primary objective is to confirm the reduction of postprandial glycemic and insulinemic response after consumption of 500 ml glucose-free apple juice compared to 500 ml untreated apple juice as could be shown in a previous study

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Males aged ≥ 18y
  2. Impaired fasting glucose (IFG)
  3. Written informed consent
  4. Consent to collect stools and urine four times for three days

Exclusion

Exclusion Criteria:

  1. Subjects currently enrolled in another clinical study
  2. Subjects having finished another clinical study within the last 4 weeks beforeinclusion.
  3. Subjects having participated in the study HB-RCT1-2015
  4. Hypersensitivity, allergy or idiosyncratic reaction to apple, apple juice or otherapple containing food
  5. Acute or chronic infections
  6. Renal insufficiency
  7. Gastrointestinal illness
  8. No stools of type 5-7 of Bristol Stool Form Scale within the last week beforeinclusion
  9. History of gastrointestinal surgery
  10. Known fructose intolerance
  11. Overt diabetes mellitus
  12. Endocrine disorders
  13. Any disease or condition which might compromise significantly the hematopoietic,renal, endocrine, pulmonary, hepatic, cardiovascular, immunological, central nervous,dermatological or any other body system with the exception of the conditions definedby the inclusion criteria
  14. History of hepatitis B and C
  15. History of HIV infection
  16. History of coagulation disorders or pharmaceutical anti-coagulation (with theexception of acetylsalicylic acid)
  17. Regular medical treatment including OTC, which may have impact on the study aims (e.g.gluconic acid-containing OTCs, antidiabetic drugs, laxatives etc.)
  18. Major cognitive or psychiatric disorders
  19. Subjects who are scheduled to undergo hospitalization during the study period
  20. Eating disorders (e.g. anorexia, bulimia) or special diets (e.g. vegan, vegetarian)
  21. Present drug abuse or alcoholism
  22. Legal incapacity

Study Design

Total Participants: 32
Study Start date:
October 28, 2015
Estimated Completion Date:
February 28, 2021

Study Description

Single center, double-blind, randomized controlled cross-over trial with four treatments and four time points.

The study has three primary objectives. The first primary objective is to confirm the in a previous study shown reduction of postprandial glycemic and insulinemic response after consumption of 500 ml glucose-free apple juice compared to 500 ml untreated apple juice.

The second primary objective is to show the reduction of postprandial glycemic response after consumption of 250 ml glucose-free apple juice compared to 250 ml untreated apple juice.

The third primary objective is to show the reduction of insulinemic response after consumption of 250 ml glucose-free apple juice compared to 250 ml untreated apple juice.

Secondary objectives include safety aspects, specifically the occurrence of diarrhoea in all four treatment groups, differences between treatment groups on the Bristol Stool Forms Scale, gastro-intestinal symptoms and laboratory parameters. In addition, gluconate excretion and excreted portion of ingested gluconate are of interest as well as faecal pH.

Connect with a study center

  • CRC Clinical Research Center Kiel

    Kiel, Schleswig-Holstein 24118
    Germany

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.